| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 40 |
| 1 | METHOTREXATE | 39 |
| 2 | INFLIXIMAB | 35 |
| 3 | ASPIRIN | 32 |
| 4 | ASPIRIN 325 MG | 32 |
| 5 | ASPIRIN 81 MG | 32 |
| 6 | PREDNISOLONE | 31 |
| 7 | PREDNISOLONE ORAL | 31 |
| 8 | PREDNISOLONE ORAL SOLUTION | 31 |
| 9 | ETOPOSIDE | 26 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FENOPROFEN CALCIUM | 1 | 0.0204 |
| 1 | ISOTONIC SODIUM CHLORIDE | 1 | 0.0133 |
| 2 | ALUMINUM HYDROXIDE GEL | 1 | 0.0068 |
| 3 | TOPOTECAN HYDROCHLORIDE | 12 | 0.0049 |
| 4 | MEXILETINE HYDROCHLORIDE | 2 | 0.0048 |
| 5 | CHLOROQUINE PHOSPHATE | 3 | 0.0046 |
| 6 | TOPOTECAN | 21 | 0.0034 |
| 7 | SODIUM NITROPRUSSIDE | 1 | 0.0026 |
| 8 | TRIMIPRAMINE MALEATE | 1 | 0.0025 |
| 9 | MEGNESIUM OXIDE | 1 | 0.0024 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 71 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 61 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 58 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 39 |
| 4 | Platinum-based Drug [EPC] | 34 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 32 |
| 6 | Topoisomerase Inhibitor [EPC] | 32 |
| 7 | Benzodiazepine [EPC] | 28 |
| 8 | Vitamin C [EPC] | 21 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 20 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adrenal Steroid Synthesis Inhibitor [EPC] | 1 | 0.0010 |
| 1 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 5 | 0.0006 |
| 2 | Topoisomerase Inhibitor [EPC] | 32 | 0.0004 |
| 3 | Thrombopoietin Receptor Agonist [EPC] | 5 | 0.0003 |
| 4 | Provitamin D2 Compound [EPC] | 8 | 0.0003 |
| 5 | Vasopressin V2 Receptor Antagonist [EPC] | 4 | 0.0003 |
| 6 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 7 | Antifibrinolytic Agent [EPC] | 2 | 0.0002 |
| 8 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 9 | Prostaglandin E1 Analog [EPC] | 3 | 0.0002 |